THYMOPENTIN

N-(N-(N-(N2-L-Arginyl-L-lysyl)-L-alpha-aspartyl)-L-valyl)-L-tyrosine; Thymopentine; Thymopentinum; Timopentina; Thymopoietin pentapeptide; Arg-Lys-Asp-Val-Tyr; Sintomodulina; Mepentil; Timunox; TP-5; (3S)-3-(((2S)-6-amino-2-(((2S)-2-amino-5-(diaminomethylideneamino) pentanoyl) amino) hexanoyl) amino)-4-(((2S)-1-(((2S)-1-hydroxy-3-(4-hydroxyphenyl)-1-oxopropan-2-yl)amino)-3-methyl-1- oxobutan- 2-yl)amino)-4-oxobutanoic acid;

 THYMOPENTIN

PRODUCT IDENTIFICATION

CAS RN

69558-55-0, 177966-81-3 (acetate)

EINECS RN

 

FORMULA

C30H49N9O9

MOLE WEIGHT

679.76

CLASSIFICATION

Bioactive peptide / Immunoregulator

 

PHYSICAL AND CHEMICAL PROPERTIES

PHYSICAL STATE

white powder

MELTING POINT

 

BOILING POINT

 

DENSITY

 

SOLUBILITY IN WATER

Soluble

pH

 

VAPOR DENSITY

 

REFRACTIVE INDEX

 

FLASH POINT

 

 

STABILITY AND REACTIVITY
STABILITY Stable under normal conditions.

INCOMPATIBLE MATERIALS

Strong oxidizing agents

DECOMPOSITION PRODUCTS

Carbon monoxide, Carbon dioxide, Nitrogen oxides.

POLYMERIZATION Has not been reported

NFPA RATINGS

 

 

SAFETY

HAZARD NOTES

Target Organ Effect. Target Organs: Immune system.

EYE

May cause eye irritation.

SKIN

May be harmful if absorbed through skin. May cause skin irritation.

INGESTION

May be harmful if swallowed.

INHALATION

May be harmful if inhaled. May cause respiratory tract irritation.

CHRONIC

 

 

TRANSPORT & REGULATORY INFORMATION

UN NO.

 
HAZARD CLASS

 

PACKING GROUP

 

HAZARD SYMBOL

 

RISK PHRASES

 

SAFETY PHRASES

 

 

EXTERNAL LINKS & GENERAL INFORMATION
Thymopentin, also known as TP-5, is a synthesized derivative of thymopoietin, a naturally occurring hormone responsible for inducing T-cell precursors to differentiate and mature. A study at the Istituto di Patologia Medica in Bari, Italy, reported thymopentin-related increases in T4 cells and some improvement in symptoms for 21 people. Two studies of thymopentin published at the Sixth International Conference on AIDS pointed to stabilization of T-helper counts and p24 antigenemia in asymptomatic and mildly symptomatic patients during treatment with thymopentin. One of the studies was too small to see differences in disease progression. In the larger study, none of the treated patients progressed to symptoms, compared to four of the placebo patients who did progress. No side effects were attributed to thymopentin (http://www.aids.org/)

A synthetic pentapeptide which is the active site of the naturally occurring hormone thymopoietin with immunomodulating properties. Thymopentin enhances the production of thymic T cells and may help restore immunocompetence in immunosuppressed subjects. This agent also augments the effects of ionizing radiation by arresting cancer cells in the G2/M phase of the cell cycle.(http://www.cancer.gov/)

Thymopentin is a synthetic pentapeptide. It can modulate immune system. Laboratories research and clinical results both show that it normalizes the immune function in two directions (promoting or inhibiting) in various cases of derangement, whether in suppression or hypersensitivity. Thus it is emerging as an immune regulatory agent with great potential. Besides its activity in the immune system, it was discovered to reduce the content of propane dialdehyde in brain, thymus and liver, enhance the activity of SOD at the same moment of improving its content, thus eliminate the radicals in human body and reduce the level of lipid peroxides. All the above illuminate that it has affects against aging and some circulatory system diseases. (http://thymosin.net/)

 

 

SALES SPECIFICATION

APPEARANCE

white to slightly yellowish powder
IDENTIFICATION

pass (HPLC)

PURITY

98.0% min

AMINO ACID 1.0 ± 10% (each theoretical Composition)

RELATED SUBSTANCES

2.0% max (total impurity), 1.0% max (Individual impurity)

PEPTIDE CONTENT
80.0% min (N determination)
pH 7.0 ~ 9.0
WATER CONTENT 8.0% max
OPTICAL ROTATION -14.0° ~ -22.0°
BACTERIAL ENDOTOXINS 5EU/mg max

 

PACKING

 

 

PRICE INFORMATION

click to open the table

 

Clik to close the table